198 related articles for article (PubMed ID: 8180608)
1. Incidence of non-Hodgkin's lymphoma in patients treated for Hodgkin's disease.
Prósper F; Robledo C; Cuesta B; Rifón J; Borbolla JR; Pardo J; Rocha E
Leuk Lymphoma; 1994 Feb; 12(5-6):457-62. PubMed ID: 8180608
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
3. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
4. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
[TBL] [Abstract][Full Text] [Related]
5. Second solid malignancies after combined modality therapy for Hodgkin's disease.
Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
[TBL] [Abstract][Full Text] [Related]
6. Second malignancies after Hodgkin's disease: the Munich experience.
Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
[TBL] [Abstract][Full Text] [Related]
7. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
[TBL] [Abstract][Full Text] [Related]
9. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
[TBL] [Abstract][Full Text] [Related]
10. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease: study of treatment intensities and incidences of second malignancies.
Rodriguez MA; Fuller LM; Zimmerman SO; Allen PK; Brown BW; Munsell MF; Hagemeister FB; McLaughlin P; Velasquez WS; Swan F
Ann Oncol; 1993 Feb; 4(2):125-31. PubMed ID: 8448080
[TBL] [Abstract][Full Text] [Related]
12. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
15. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Tsimberidou AM; Sarris AH; Medeiros LJ; Mesina O; Rodriguez MA; Hagemeister FB; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F
Leuk Lymphoma; 2001 May; 41(5-6):535-44. PubMed ID: 11378571
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time.
Foss Abrahamsen A; Andersen A; Nome O; Jacobsen AB; Holte H; Foss Abrahamsen J; Kvaløy S
Ann Oncol; 2002 Nov; 13(11):1786-91. PubMed ID: 12419752
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
[TBL] [Abstract][Full Text] [Related]
19. [Secondary non-Hodgkin's lymphomas].
Cappelaere P
Bull Cancer; 1998 Mar; 85(3):217-31. PubMed ID: 9752310
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphomas arising in patients successfully treated for Hodgkin's disease. A clinical, histologic, and immunophenotypic study of 14 cases.
Zarate-Osorno A; Medeiros LJ; Longo DL; Jaffe ES
Am J Surg Pathol; 1992 Sep; 16(9):885-95. PubMed ID: 1415907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
